BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 8, 2017
View Archived Issues
Sanofi reflects on accomplishments of first quarter 2017
Read More
Shire reviews progress of first quarter 2017
Read More
Vaccine against respiratory syncytial virus ChAd155-RSV safe in first-in-human study
Read More
Repurposing trazodone hydrochloride and dibenzoylmethane for the treatment of dementia
Read More
Teprotumumab demonstrates clinical benefit in patients with thyroid-associated ophthalmopathy
Read More
EC approves Merck & Co.'s Keytruda in classical Hodgkin's lymphoma
Read More
FDA approves Radicava for ALS
Read More
Achaogen, Bill & Melinda Gates Foundation partner to prevent neonatal sepsis in developing countries
Read More
Bristol-Myers Squibb initiates phase II trial of BMS-986168 in progressive supranuclear palsy
Read More
Phase I data presented for acid pump antagonist DWP-14012
Read More
Aridis conducts phase II trial of Aerucin for P. aeruginosa pneumonia
Read More
CONCERTO trial of laquinimod in RRMS fails to meet primary endpoint
Read More
Proterris and Alfama merger completed
Read More
New animal model reproduces hepatitis D virus infection
Read More
Faron's phase III trial of Traumakine in ARDS cleared to continue by IMDC
Read More
Bristol-Myers Squibb divulges novel NR2B receptor ligands
Read More
Immunocore identifies new ImmTAC lead molecule under collaboration with GSK
Read More
Princeton Drug Discovery patents protein kinase inhibitors
Read More
Bayer describes new antiangiogenic compounds
Read More
Esteve discloses new sigma1-receptor ligands
Read More
Mitsubishi Tanabe Pharma presents novel KAT II inhibitors
Read More
Neuform Pharmaceuticals identifies new IDH2 inhibitors
Read More
Preclinical data presented for [18F]ODS-2004436, a TKI-PET radiotracer targeting EGFR
Read More
Novel BRD4 inhibitors patented by the NEOMED Institute
Read More
BioLineRx's meeting with FDA paves way for pivotal study of BL-8040 for stem cell mobilization
Read More
Horizon Pharma to acquire River Vision Development
Read More